Baseline neutrophil-to-lymphocyte ratio (NLR) is associated with outcome of patients treated with BRAF inhibitors

MLA

S. Stucchi, et al. “Baseline Neutrophil-to-Lymphocyte Ratio (NLR) Is Associated with Outcome of Patients Treated with BRAF Inhibitors.” Clinicaltranslational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, vol. 22, no. 10, Jan. 2020. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7c722666a6b009728582874d7dbc7c84&authtype=sso&custid=ns315887.

APA

S. Stucchi, Emilia Cocorocchio, Pier Francesco Ferrucci, Sara Gandini, Chiara Martinoli, Laura Pala, Fabio Conforti, & Giovanni Mazzarol. (2020). Baseline neutrophil-to-lymphocyte ratio (NLR) is associated with outcome of patients treated with BRAF inhibitors. Clinicaltranslational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 22(10).

Chicago

S. Stucchi, Emilia Cocorocchio, Pier Francesco Ferrucci, Sara Gandini, Chiara Martinoli, Laura Pala, Fabio Conforti, and Giovanni Mazzarol. 2020. “Baseline Neutrophil-to-Lymphocyte Ratio (NLR) Is Associated with Outcome of Patients Treated with BRAF Inhibitors.” Clinicaltranslational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 22 (10). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....7c722666a6b009728582874d7dbc7c84&authtype=sso&custid=ns315887.